345 results
Page 10 of 18
8-K
EX-99.1
lq3r8 yrj
24 Aug 12
Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C
12:00am
8-K
thuxkel5p agkj0yx7k
24 Aug 12
Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C
12:00am
8-K
EX-99.1
acb7zg5i71b3s0lr4p
3 Aug 12
Bristol-Myers Squibb Suspends Administration of Study Drug in Clinical Trial of Investigational NS5B Nucleotide for the Treatment of Hepatitis C
12:00am
8-K
EX-4.4
e46ztd
31 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.3
j92 5ikyir89qnm
31 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
q52gpl
31 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.2
oxvie4dwamwq wjku
31 Jul 12
Entry into a Material Definitive Agreement
12:00am
424B5
0nw7txt uwf
27 Jul 12
Prospectus supplement for primary offering
12:00am
424B3
h0zarytjtug1ao14g2l2
26 Jul 12
Prospectus supplement
12:00am
8-K
EX-2.1
jitfgzpy
3 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
vdsld2 ww3ntzu7b1u3
26 Jan 12
Net Sales Rise 7% to $5.5 Billion in Fourth Quarter
12:00am